Arrowhead Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. 

CEO
Christopher Richard Anzalone
CEOChristopher Richard Anzalone
Employees
609
Employees609
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
1989
Founded1989
Employees
609
Employees609

ARWR Key Statistics

Market cap
2.31B
Market cap2.31B
Price-Earnings ratio
-13.68
Price-Earnings ratio-13.68
Dividend yield
Dividend yield
Average volume
1.53M
Average volume1.53M
High today
$19.33
High today$19.33
Low today
$16.67
Low today$16.67
Open price
$19.05
Open price$19.05
Volume
3.01M
Volume3.01M
52 Week high
$29.86
52 Week high$29.86
52 Week low
$9.57
52 Week low$9.57

ARWR News

Simply Wall St 12h
Insiders At Arrowhead Pharmaceuticals Sold US$3.1m In Stock, Alluding To Potential Weakness

The fact that multiple Arrowhead Pharmaceuticals, Inc. ( ) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows...

Insiders At Arrowhead Pharmaceuticals Sold US$3.1m In Stock, Alluding To Potential Weakness

Analyst ratings

67%

of 15 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own ARWR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.